Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Congress

November 07, 2018 | Daily News

With Democrats taking control of the House, Rep. Frank Pallone (D-NJ) is highly expected to chair the powerful Energy & Commerce Committee, and, although he comes from a pharmaceutical-heavy district, he told Inside Health Policy prior to the election results that tackling high drug prices would be a top priority as would overseeing the administration's health care agenda.

November 07, 2018 | Daily News

Prior to the midterm elections, Senate Democratic staffers prepared for a split Congress, with a GOP-controlled Senate and a Democratic House, by meeting with health care stakeholders and their House counterparts to coordinate next steps and make plans to re-frame the push for Obamacare market stabilization as a way to protect people with preexisting conditions, sources close to the Senate health committee say.

November 07, 2018 | Daily News

House Democrats promise to take on drug prices when they take control of the House next year, but the actual likelihood of aggressive measures becoming law depends largely on whether they will work with the president on legislation and, if so, whether the president can get Senate Republican leaders in line. However, President Donald Trump is pursuing administrative changes to lower drug prices that don't require Congress' blessing, and congressional Democrats may find themselves walking a fine line between not wanting to help Trump and delivering on their own promises to lower drug prices.

November 07, 2018 | Daily News

With a Democratic takeover of the House, the powerful Energy & Commerce Committee will experience leadership and priority shifts. A former congressional aide told Inside Health Policy that Democrats may use the opportunity to push the Creating and Restoring Access to Equivalent Samples (CREATES) Act, seek funding options for opioid-related initiatives, focus more on cosmetics legislation and revisit laboratory-developed test (LDT) legislation.

November 06, 2018 | Daily News

No matter how the midterm elections play out on Nov. 6, the National Organization for Rare Disorders is confident that congressional support for a key bill, which would offer incentives to companies repurposing drugs for rare diseases, will remain strong and bipartisan even as the bill’s main sponsor in the Senate heads toward retirement, the organization’s director told Inside Health Policy.

November 05, 2018 | Daily News

In the run up to the 2018 midterms, the Center for Medicare Advocacy and the Medicare Rights Center are warning that Medicare is under threat, and urging voters to support the program.

November 05, 2018 | Daily News

Opinions are divided over whether Democrats would work with Republicans on drug price legislation if Democrats win the House.

November 05, 2018 | Daily News

After the midterms on Tuesday, the House Energy & Commerce Committee will prepare itself for the retirements of two of its senior members, health subcommittee ranking Democrat Rep. Gene Green (TX) and committee Vice Chair Rep. Joe Barton (R-TX), as well as the departure of Rep. Ryan Costello (R-PA).

November 05, 2018 | Daily News

The dietary supplements lobby has its hopes on Sen. Martin Heinrich (D-NM), who is slated by polls to defend his seat and keep his role as supporter of the supplement industry, which will say goodbye to its longtime champion in the Senate, Sen. Orrin Hatch (R-UT) in January.

November 02, 2018 | Daily News

Democratic lawmakers who are in line for leadership positions if House Democrats take control after the midterm elections have made curbing prescription drug prices one of their top issues.

November 02, 2018 | Daily News

The Advanced Medical Technology Association (AdvaMed) is confident that the interests of the medical device industry will be well-represented no matter which party controls the House and the Senate after the midterm elections due to the industry's support from both parties.

November 02, 2018 | Daily News

Lobbyists and analysts say congressional Republicans haven’t criticized President Donald Trump’s plan to base Part B drug rates on international prices because Republicans don’t know whether the administration is serious about the plan and they don’t want to get in the way of a good campaign issue.

October 26, 2018 | Daily News

A key White House health care official called on Congress to undo changes it made to the Medicare Part D prescription drug donut hole earlier this year, siding with drug makers that are lobbying to unravel the change that increased the industry’s share of costs in the coverage gap.

October 25, 2018 | Daily News

The issue of how to stabilize the Affordable Care Act's individual market, until recently a prime focus of health policy debates, has receded from center stage in midterm campaigning as candidates turned to politically salient topics such as protections for people with preexisting conditions and the debate over single-payer.

October 25, 2018 | Daily News

The issue of how to stabilize the Affordable Care Act's individual market, until recently a prime focus of health policy debates, has receded from center stage in midterm campaigning as candidates turned to politically salient topics such as protections for people with preexisting conditions and the debate over single-payer.

October 25, 2018 |

Democratic Sens. Elizabeth Warren (MA) and Tina Smith (MN) are asking HHS Secretary Alex Azar to provide additional information in support of his allegations in congressional testimony this summer that drug-channel middlemen are thwarting drug company efforts to lower list prices.

October 24, 2018 | Daily News

Veteran election handicapper Charlie Cook believes deep budget cuts to social programs, including Medicaid, in some red states could hurt Republican candidates running for gubernatorial and state legislative seats in next month's midterm elections.

October 24, 2018 | Daily News

President Donald Trump on Wednesday (Oct. 24) signed into law the massive bicameral package of opioid legislation, which the Senate passed Oct. 3.

October 19, 2018 | Daily News

Senate Majority Leader Mitch McConnell (R-KY) is defending the administration's decision to ask a federal court to throw out the Affordable Care Act's protections for people with preexisting conditions if it finds the mandate is no longer valid, and suggested that a win would allow the GOP to “start over” on health care reforms.

October 18, 2018 | Daily News

Democrats have exhausted their immediate legislative options to block the expansion of short-term health plans, leaving the upcoming federal court case as the party's best chance to restrict so-called junk insurance policies prior to the midterms or the start of Obamacare open enrollment.

Pages